Alpelisib is a Selective and Orally Active PI3Kα Inhibitor for
Selective inhibitory activity of 9l towards H3K79 methylation in
BC-LI-0186 is a Selective Inhibitor of LeuRS and RagD Interaction
Molecules, Free Full-Text
Trilaciclib is an Orally Active CDK4 and CDK6 Inhibitor
Established synthetic method of psammaplin A analog and
OT-82 is an Orally Active NAMPT Inhibitor with Antineoplastic Activity
Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to
SG-094 is a Potent TPC2 Inhibitor for HCC Reasearch